2025-10-05 - Analysis Report
Okay, here's an analysis of IRBT (iRobot Corp) based on the provided data.

**Report: iRobot Corp (IRBT) Analysis**

iRobot Corp. designs, builds, and sells robots for the home.

**1. Performance vs. S&P 500 (VOO)**

*   **IRBT Cumulative Return:** -64.15%
*   **VOO Cumulative Return:** 98.51%
*   **Absolute Divergence:** -162.66%
*   **Divergence Range:** (Max: 150.4, Min: -168.3, Current: -164.6)
*   **Relative Divergence:** 1.2 (Indicates IRBT is near its historical low relative to VOO)

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 77.0%   | 67.0%   | 48.0%   | 0.1    | 2.4    |
| 2016-2018  | 69.0%   | 74.9%   | 54.0%   | 0.1    | 2.6    |
| 2017-2019  | -68.0%  | 74.9%   | -90.0%  | 0.2    | 1.6    |
| 2018-2020  | -62.0%  | 75.9%   | -86.0%  | 0.1    | 2.5    |
| 2019-2021  | -90.0%  | 75.9%   | -136.0% | 0.1    | 2.1    |
| 2020-2022  | -29.0%  | 75.9%   | -28.0%  | -0.3   | 1.5    |
| 2021-2023  | -142.0% | 75.5%   | -143.0% | -0.2   | 1.2    |
| 2022-2024  | -69.0%  | 85.8%   | -89.0%  | -0.3   | 0.2    |
| 2023-2025  | -16.0%  | 85.8%   | -79.0%  | -0.1   | 0.1    |

**Analysis:**

*   **Significant Underperformance:** IRBT has significantly underperformed the S&P 500, with a large negative cumulative return and persistent negative alpha values. This indicates a long-term failure to generate excess returns relative to the market.
*   **High Volatility:** The MDD (Maximum Drawdown) figures are very high, suggesting substantial price volatility and risk.
*   **Beta:** The Beta values vary but are generally around 0.1-0.2 or even negative (-0.3), indicating that the stock is less sensitive to market movements. However, given the negative performance and high MDD, this could simply reflect IRBT's own idiosyncratic risks rather than true market insensitivity.

**2. Recent Stock Price Movement**

*   **Current Price:** $4.22
*   **Previous Close:** $3.99
*   **Change:** 5.76% (Significant upward movement)
*   **5-Day Moving Average:** 3.81
*   **20-Day Moving Average:** 3.7655
*   **60-Day Moving Average:** 3.9008

**Analysis:**

*   **Short-Term Uptrend:** The current price is above all moving averages, suggesting a short-term upward trend. The 5.76% jump in price, with the stock price ($4.22) being well above all averages, signals strong positive momentum potentially triggered by recent news or market sentiment.

**3. Market Risk Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 56.11 (Neutral, neither overbought nor oversold)
*   **PPO:** 0.83 (Positive, suggesting upward momentum)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (250 shares - Very Safe - MRI:0.90)
*   **Recent (20-Day) Relative Divergence Change:** 1.2 (+) (Short-term increase)
*   **Expected Return (%):** -9371.0 (Extremely negative, suggesting substantial underperformance vs. S&P 500 over a long-term investment horizon)

**Analysis:**

*   **Conflicting Signals:** While the MRI suggests a relatively safe investment, the expected return is extremely negative. The RSI is neutral. The PPO and recent divergence change indicate short-term upward momentum.
*   **Hybrid Signal:** The hybrid signal advocating for a full cash investment into IRBT with a "Very Safe" label seems highly contradictory given the other indicators and historical performance. The MRI might be lagging or not fully capturing the specific risks associated with IRBT.
*   **Caution Advised:** The large price change (5.76%) should be considered in context with other indicators. A potential 'dead cat bounce' phenomenon, where a brief recovery occurs after a significant decline, should be considered.

**4. Recent News & Significant Events**

*   **Negative Sentiment:** "Famed roboticist says humanoid robot bubble is doomed to burst" (Potentially affects sentiment towards robotics companies).
*   **Market Report:** "Cleaning Robot Global Market Analysis Report 2025-2033" (General industry data).
*   **Company Evaluation:** "Smart Robots Company Evaluation Report 2025 | iRobot, SoftBank Robotics, and ABB Lead Innovations..." (Positions iRobot among leading innovators).
*   **Earnings Report:** iRobot Second Quarter 2025 Earnings: Beats Expectations (Positive, potentially driving recent price increase).
*   **Earnings Snapshot & Report:** IRobot: Q2 Earnings Snapshot, iRobot Reports Second-Quarter 2025 Financial Results (Reinforce the earnings beat).

**Analysis:**

*   **Mixed Signals:** The news is a mix of positive (earnings beat) and potentially negative (humanoid robot bubble concerns). The market reports provide general industry context.
*   **Earnings Impact:** The earnings beat likely contributed to the recent price surge.

**4-2) Analyst Opinions:**

*   **Consensus:** None
*   **Mean Target Price:** $11.94
*   **Opinions:** 1

**Analysis:**

*   **Limited Coverage:** The lack of a consensus and the single opinion suggest limited analyst coverage or strong disagreement.
*   **Upside Potential:** The target price of $11.94 suggests significant upside potential if analysts' expectations are met, but this should be viewed with caution due to the limited data.

**5. Earnings Analysis**

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-08-07 | -0.68 | $0.13B     |
| 2025-05-06 | -2.84 | $0.10B     |
| 2024-11-06 | -0.21 | $0.19B     |
| 2024-08-07 | -2.41 | $0.17B     |
| 2025-08-07 | -2.41 | $0.17B     |

**Analysis:**

*   **Inconsistent EPS:** Earnings per share (EPS) is consistently negative, indicating ongoing losses.  While the latest EPS is improved, it's still negative.
*   **Fluctuating Revenue:** Revenue fluctuates quarter to quarter.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.13B  | 30.02%        |
| 2025-03-31 | $0.10B  | 20.00%        |
| 2024-12-31 | $0.17B  | 9.54%         |
| 2024-09-30 | $0.19B  | 32.25%        |
| 2024-06-30 | $0.17B  | 16.51%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE         |
|------------|-----------|-------------|
| 2025-06-30 | -$0.01B   | 296.52%     |
| 2025-03-31 | -$0.00B   | 11005.42%   |
| 2024-12-31 | $0.06B    | -125.91%    |
| 2024-09-30 | $0.15B    | -4.24%      |
| 2024-06-30 | $0.15B    | -47.39%     |

**Analysis:**

*   **Negative Equity:** The negative equity in recent quarters is a significant concern, suggesting financial distress.
*   **Extremely High ROE (Return on Equity):**  The exceptionally high ROE values are misleading and are likely a result of the negative equity. When equity is negative, ROE calculations become distorted and unreliable.
*   **Profit Margin Variability:** Profit margins fluctuate, indicating a lack of consistent profitability.

**7. Overall Summary**

iRobot (IRBT) presents a highly speculative investment opportunity with significant risks.

*   **Negative Long-Term Performance:** The company has significantly underperformed the S&P 500 with a history of negative alpha.
*   **Financial Distress:** Negative equity, inconsistent EPS, and fluctuating revenue and profit margins raise serious concerns about the company's financial health.
*   **Short-Term Momentum:**  A recent earnings beat has driven a price surge, suggesting potential short-term upward momentum.  However, this should be viewed with caution and considered a possible 'dead cat bounce.'
*   **Conflicting Signals:** Market risk indicators and hybrid signals are contradictory and should not be relied upon without considering the broader financial context.
*   **Analyst Uncertainty:** Limited analyst coverage and a wide range of target prices highlight the uncertainty surrounding the company's future prospects.

**Recommendation:**

Given the significant financial risks and historical underperformance, **investing in IRBT is not recommended** for risk-averse investors.  The recent price surge may present a short-term trading opportunity, but a thorough understanding of the risks and careful monitoring are essential. A deeper analysis of the company's debt, cash flow, and strategic plans is necessary before considering a long-term investment.
